These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8124307)

  • 1. The difficulties of treating infection in adults with cystic fibrosis.
    Webb AK
    Monaldi Arch Chest Dis; 1993 Dec; 48(6):657-61. PubMed ID: 8124307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
    Eber E; Zach MS
    Thorax; 2010 Oct; 65(10):849-51. PubMed ID: 20861286
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
    Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
    J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis.
    Høiby N
    Chest; 1988 Aug; 94(2 Suppl):97S-103S. PubMed ID: 3293941
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.
    Høiby N; Koch C
    Thorax; 1990 Nov; 45(11):881-4. PubMed ID: 2256020
    [No Abstract]   [Full Text] [Related]  

  • 7. [Improving the management of chronic
    She DY
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):733-735. PubMed ID: 35927042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary infection in cystic fibrosis.
    Friend PA
    J Infect; 1986 Jul; 13(1):55-72. PubMed ID: 3090153
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral infections trigger exacerbations of cystic fibrosis in adults and children.
    Wark PA; Tooze M; Cheese L; Whitehead B; Gibson PG; Wark KF; McDonald VM
    Eur Respir J; 2012 Aug; 40(2):510-2. PubMed ID: 22855475
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
    Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
    Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of respiratory viral infections in cystic fibrosis.
    Flight W; Jones A
    Expert Rev Respir Med; 2017 Mar; 11(3):221-227. PubMed ID: 28132571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory therapies for cystic fibrosis.
    Thompson AB; Smits WL; Fick RB
    Semin Respir Infect; 1992 Sep; 7(3):218-26. PubMed ID: 1475545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
    McIsaac SM; Stadnyk AW; Lin TJ
    J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe viral respiratory infections in infants with cystic fibrosis.
    Armstrong D; Grimwood K; Carlin JB; Carzino R; Hull J; Olinsky A; Phelan PD
    Pediatr Pulmonol; 1998 Dec; 26(6):371-9. PubMed ID: 9888211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa infection and cystic fibrosis.
    Kato K; Takayama T
    Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
    [No Abstract]   [Full Text] [Related]  

  • 17. High peripheral blood th17 percent associated with poor lung function in cystic fibrosis.
    Mulcahy EM; Hudson JB; Beggs SA; Reid DW; Roddam LF; Cooley MA
    PLoS One; 2015; 10(3):e0120912. PubMed ID: 25803862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
    Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
    Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.